The expression levels of APAF1 were correlated with scores for parkinsonism, as measured by the UPDRS and PDQ-39, while the expression levels of CSF1R were negatively correlated with scores for cognitive function, as measured by the MMSE and MoCA. Here, APAF1 is linked to Parkinson disease.